Clinical Trial Update: Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the diagnostic performance of [18F]FES PET/CT to detect axillary lymph node metastasis in invasive lobular carcinoma; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Lobular Carcinoma

Drugs mentioned

• [18F]FES PET/CT (fluoroestradiol PET/CT imaging agent)

Snippet

Sponsor: Asan Medical Center | Conditions: Carcinoma, Lobular | Phase 2 | Status: COMPLETED